Shandong Polymer Biochemicals Co., Ltd.
Symbol: 002476.SZ
SHZ
4.61
CNYDzisiejsza cena rynkowa
-1078.4464
Wskaźnik P/E
12.5889
Wskaźnik PEG
2.82B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Shandong Polymer Biochemicals Co., Ltd. (002476-SZ) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1259.11 | 305.6 | 401 | 361.8 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0.31 | 0.3 | 0 | -18.6 | ||||||||||||||||
balance-sheet.row.net-receivables | 1010.97 | 365.1 | 248.1 | 127.9 | ||||||||||||||||
balance-sheet.row.inventory | 426.51 | 84.5 | 82 | 65.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 15.57 | 6.6 | 24.1 | 13.5 | ||||||||||||||||
balance-sheet.row.total-current-assets | 2712.15 | 761.7 | 755.1 | 568.9 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 745.39 | 182.4 | 200.8 | 390 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 278.39 | 79.5 | 8.5 | 31.5 | ||||||||||||||||
balance-sheet.row.tax-assets | 20.63 | 5.8 | 6.5 | 7.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 24.19 | 0.4 | 10.8 | 1.2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 1510.49 | 278.2 | 237.3 | 441.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.account-payables | 262.9 | 134.6 | 63.1 | 58.5 | ||||||||||||||||
balance-sheet.row.short-term-debt | 60.91 | 11.4 | 1.4 | 43.1 | ||||||||||||||||
balance-sheet.row.tax-payables | 14.29 | 3.2 | 3.9 | 2.1 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 77.9 | ||||||||||||||||
Deferred Revenue Non Current | 4.77 | 1.3 | 1.5 | 1.7 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.34 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 40.68 | 22.8 | 12 | 0.5 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 5.11 | 1.3 | 1.7 | 79.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 2.3 | 1.4 | 0.1 | 77.9 | ||||||||||||||||
balance-sheet.row.total-liab | 497.51 | 170.4 | 152.4 | 188 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 2448 | 612 | 612 | 612 | ||||||||||||||||
balance-sheet.row.retained-earnings | 108.28 | 29.1 | -0.5 | -18.5 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 568.62 | 53.5 | 53.5 | 53.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 349.96 | 175 | 175 | 175 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3474.86 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.minority-interest | 250.28 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 3725.13 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 4222.64 | - | - | - | ||||||||||||||||
Total Investments | 278.39 | 79.5 | 8.5 | 12.9 | ||||||||||||||||
balance-sheet.row.total-debt | 60.91 | 11.4 | 1.6 | 43.1 | ||||||||||||||||
balance-sheet.row.net-debt | -1198.2 | -294.2 | -399.4 | -318.8 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 9.59 | 34.9 | 38.8 | 40.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0.69 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -0.7 | 0.2 | -3.9 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -164.92 | -153.9 | -101.8 | -33.6 | ||||||||||||||||
cash-flows.row.account-receivables | -161.99 | -162 | -206.5 | -52.2 | ||||||||||||||||
cash-flows.row.inventory | -2.92 | -2.9 | -15.9 | 25.2 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 10.3 | 120.9 | -10.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 108.17 | 11.2 | 10.2 | 12.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 104.27 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | -71.17 | 5.5 | 117.5 | 2.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -40 | -80 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1.9 | 1.9 | 22.6 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | -65.64 | 0.9 | -1.7 | 24.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -117.35 | -86.7 | 119.5 | 8.8 | ||||||||||||||||
cash-flows.row.debt-repayment | -21.82 | -9.9 | -30.3 | -67 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -0.57 | -0.4 | -5.7 | -10.4 | ||||||||||||||||
cash-flows.row.other-financing-activites | 24.81 | 17.7 | -12 | 7 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 4.15 | 7.3 | -48 | -70.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.91 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -8.02 | -157.6 | 36.6 | -29.1 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1184.3 | 240.6 | 398.2 | 361.5 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1192.32 | 398.2 | 361.5 | 390.7 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 104.27 | -78.2 | -34.8 | 32.5 | ||||||||||||||||
cash-flows.row.capital-expenditure | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 92.56 | -93.2 | -54 | 14.9 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 479.79 | 592.3 | 657.2 | 447.3 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 384.21 | 462.7 | 557.1 | 363.6 | ||||||||||||||||
income-statement-row.row.gross-profit | 95.58 | 129.6 | 100.1 | 83.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 18.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 11.99 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 98.38 | 100.8 | 76.8 | 58.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 482.59 | 563.5 | 633.9 | 421.9 | ||||||||||||||||
income-statement-row.row.interest-income | 6.13 | 6.7 | 5.4 | 5.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -4.07 | 36.9 | 38.8 | 40.6 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -4.59 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -0.52 | 30.7 | 25.3 | 26.8 | ||||||||||||||||
income-statement-row.row.income-before-tax | -2.13 | 31.1 | 17.7 | 17.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -0.07 | 1.4 | -0.2 | 3.9 | ||||||||||||||||
income-statement-row.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 |
Często zadawane pytania
Ile wynosi Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) aktywów ogółem?
Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) całkowite aktywa to 1039968863.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 212096636.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.199.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.151.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to -0.004.
Jaki jest całkowity przychód firmy?
Całkowity przychód to -0.001.
Co to jest Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 29630378.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 11381167.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 100833128.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 314019731.000.